IP Library Granted Patent US 9,585,818
Granted Patent B2
US 9,585,818 · App. 14/251,284 · Granted Mar 7, 2017

Enamel protectant and repair toothpaste treatments

Inventors: William A. Mchale (Collegeville, PA); Dale G. Brown (Wharton, TX)
Assignee: Premier Dental Products Company
A61K8/21A61K8/23A61K8/362A61K8/365A61K8/891A61K8/90A61Q11/00A61K2800/31
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,585,818
App. No.
14/251,284
Granted
Mar 7, 2017
Kind
B2
Abstract

Substantially aqueous-free, enamel protectant and enamel repair toothpaste treatments containing: stannous fluoride, calcium and a substantivity agent comprising: an emulsion of polydimethylsiloxane in a nonionic surfactant, wherein: (a) substantivity of said stannous fluoride and calcium into biofilm present on enamel is enhanced through calcium binding shifting from bidentate to monodentate in the presence of stannous fluoride; and (b) said toothpaste treatments indicate substantially improved, enamel protectant factor (EPF) and enamel repair factor (ERF) values compared to fluoride brushing treatments with comparable or higher fluoride levels.

Claims (59)

1. An aqueous-free, enamel protectant and enamel repair, toothpaste treatments containing: stannous fluoride and calcium in a substantivity agent selected from emulsions of polymethylsiloxanes in nonionic poloxamer surfactants, wherein:

(a) Substantivity of said stannous fluoride and calcium into biofilm present on enamel is enhanced through a shift in calcium binding from bidentate to monodentate in the presence of stannous fluoride;

(b) EPF and ERF values of at least 2.5 and 200, respectively, are achieved with periodic administration of said toothpastes onto enamel surfaces with biofilm present;

(c) wherein the stannous fluoride is present in an amount of 400-1100 ppm;

(d) wherein the composition has a pH of 3-5.8;

(e) wherein the calcium content is 0.5-5.0%;

(f) wherein the calcium is limited to one or more of calcium fumarate, calcium sulfate, calcium gluconate, and mixed sodium and calcium salts of methyl/vinyl/ether/maleic copolymers thereof; and

(g) wherein said nonionic poloxamer is selected from solid and liquid, nonionic poloxamers and combinations thereof.

2. A treatment according to claim 1 , wherein some of said stannous fluoride and calcium is present as CaF + .

3. A treatment according to claim 1 , wherein said substantivity agent contains linear, polymeric polycarboxylate, substantivity enhancers.

4. Substantially aqueous-free, enamel protectant and enamel repair, toothpaste treatments according to claim 3 , containing stannous fluoride and calcium in a substantivity agent comprising an emulsion of polydimethylsiloxane polymer at viscosities from between about 10,000 cs and about 2.5 million cs as the discontinuous phase in a nonionic surfactant, continuous phase.

5. Toothpaste treatments, according to claim 4 , wherein nonionic poloxamer surfactants, suitable for said toothpastes, are represented by the structural formula:

HO[(C 2 H 4 O) x /(C 3 H 6 O) y ]—[C 3 H 6 O ] z —[(C 2 H 4 O) x /(C 3 H 6 O) y ]H

wherein the sum of x, y and z is from between 125 and 175.

6. Toothpaste treatments according to claim 3 , wherein nonionic surfactants, suitable for said toothpastes, are represented by the structural formula:

HO[(C 2 H 4 O) x /(C 3 H 6 O) y ]—[C 3 H 6 O ] z —[(C 2 H 4 O) x /(C 3 H 6 O) y ]H

wherein x =76, y =25 and z =56.

7. Toothpaste treatments, according claim 1 , containing unreacted, calcium and phosphate components.

8. An aqueous-free, enamel protectant and enamel repair, toothpaste treatments containing stannous fluoride and calcium in a substantivity agent comprising an emulsion of polydimethylsiloxane polymer at viscosities from between about 10,000 cs and about 2.5 million cs as the discontinuous phase in a nonionic poloxamer surfactant, continuous phase containing a linear polymeric polycarboxylates substantivity enhancers

wherein said nonionic surfactant is a surfactant selected from the group consisting of surfactants having the following, general, structural formula:

HO[(C 2 H 4 O) x /(C 3 H 6 O) y ]—[C 3 H 6 O] z —[(C 2 H 4 O) x /(C 3 H 6 O) y ]H

wherein the sum of x, y and z is from between 125 and 175; wherein:

(a) Substantivity of said stannous fluoride and calcium into biofilm present on enamel is enhanced through a shift in calcium binding from bidentate to monodentate in the presence of stannous fluoride;

(b) EPF and ERF values of at least 2.5 and 200, respectively, are achieved with periodic administration of said toothpastes onto enamel surfaces with biofilm present;

(c) wherein the stannous fluoride is present in an amount of 400-1100 ppm;

(d) wherein the composition has a pH of 3-5.8;

(e) wherein the calcium content is 0.5-5.0%;

(f) wherein the calcium is limited to one or more of calcium fumarate, calcium sulfate, calcium gluconate, and mixed sodium and calcium salts of methyl/vinyl/ether/maleic copolymers thereof; and

(g) wherein said nonionic poloxamer is selected from solid and liquid, nonionic poloxamers and combinations thereof.

9. Toothpaste treatments, according to claim 8 , wherein nonionic poloxamer surfactants, suitable for said toothpastes, are represented by the structural formula:

HO[(C 2 H 4 O) x /(C 3 H 6 O) y ]—[C 3 H 6 O ] z —[(C 2 H 4 O) x /(C 3 H 6 O) y ]H

wherein the sum of x, y and z is from between 125 and 150.

10. Toothpastes, according to claim 8 , wherein nonionic poloxamer surfactants, suitable for said toothpastes, are represented by the structural formula:

HO[(C 2 H 4 O) x /(C 3 H 6 O) y ]—[C 3 H 6 O ] z —[(C 2 H 4 O) x /(C 3 H 6 O) y ]H

wherein x =76, y =0 and z =56.

11. Toothpaste treatments, according claim 8 , containing unreacted, calcium and phosphate components.

12. An aqueous-free, enamel protectant and enamel repair, toothpaste treatments, featuring monodentate-bidentate bonding of calcium in the presence of stannous fluoride; containing: stannous fluoride, calcium and phosphate components, and a substantivity agent emulsion containing nonionic poloxamer surfactant as the continuous phase and polydimethylsiloxane polymer as the discontinuous phase; with an EPF of at least 2.5 and ERF of at least 200;

(a) wherein the stannous fluoride is present in an amount of 400-1100 ppm;

(b) wherein the composition has a pH of 3-5.8;

(c) wherein the calcium content is 0.5-5.0%;

(d) wherein the calcium is limited to one or more of calcium fumarate, calcium sulfate, calcium gluconate, and mixed sodium and calcium salts of methyl/vinyl/ether/maleic copolymers thereof; and

(e) wherein said nonionic poloxamer is selected from solid and liquid, nonionic poloxamers and combinations thereof.

13. Toothpaste treatments, according to claim 5 , wherein said polydimethylsiloxane polymer discontinuous phase comprises up to 20% of said emulsion.

14. An aqueous-free, enamel protectant and enamel repair, toothpaste treatments containing stable stannous fluoride and calcium on a substantivity agent selected from emulsions of polymethylsiloxanes in nonionic poloxamer surfactants, substantive to biofilm coated enamel, wherein:

(a) substantivity of said stannous fluoride and calcium into said biofilm is enhanced by a substantivity enhancer and by a shift from bidentate binding of calcium to monodentate in the presence of stable stannous fluoride;

(b) said stannous fluoride, upon release from said substantivity agent, converts to the moiety CaF + which effects EPF and ERF values of at least 2.5 and about 200, respectively;

(c) wherein the stannous fluoride is present in an amount of 400-1100 ppm;

(d) wherein the composition has a pH of 3-5.8;

(e) wherein the calcium content is 0.5-5.0%;

(f) wherein the calcium is limited to one or more of calcium fumarate, calcium sulfate, calcium gluconate, and mixed sodium and calcium salts of methyl/vinyl/ether/maleic copolymers thereof; and

(g) wherein said nonionic poloxamer is selected from solid and liquid, nonionic poloxamers and combinations thereof.

15. Toothpaste treatments, according to claim 1 , wherein said stannous fluoride, upon release from said substantivity agent, includes a CaF + moiety in the presence of said calcium monodentate binding to said biofilm present on enamel.

16. Toothpaste treatments, according to claim 1 , wherein the pH of said toothpastes, upon administration to enamel with biofilm, is about 3.

17. Toothpaste treatments, according to claim 3 , wherein the level of said substantivity agent and said substantivity enhancers is between about 0.5 and about 5% by wt. and about 0.1 and about 3% by wt., respectively.

18. Toothpaste treatments, according to claim 3 , wherein said substantivity enhancer has the structural formula:

where m is an integer that provides weight between about 60,000 and about 1,000,000.

19. Toothpaste treatments, according to claim 8 , wherein the concentration of polydimethylsiloxane is up to about 20% by wt. of said emulsion.

20. Toothpaste treatments, according to claim 14 , wherein: the ratio of unreacted calcium and phosphate components is from between about 2 and about 1, and the level of calcium and phosphate mixture in said toothpastes ranges from between about 0.2% and about 3%.

21. Toothpaste treatments, according to claim 14 , wherein: the pH of said toothpaste, upon exposure to saliva, is from between about 4 and about 8.

Assignments (3)
SECURITY INTEREST Recorded Mar 27, 2025
From: PREMIER DENTAL PRODUCTS COMPANY, LLC
To: FIDELITY DIRECT LENDING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070650/0397 →
ENTITY CONVERSION Recorded Mar 17, 2025
From: PREMIER DENTAL PRODUCTS COMPANY
To: PREMIER DENTAL PRODUCTS COMPANY, LLC
Reel/Frame 070537/0105 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2014
From: MCHALE, WILLIAM A.; BROWN, DALE G.
To: PREMIER DENTAL PRODUCTS COMPANY
Reel/Frame 032782/0624 →
Continuity (2)
Continuation In Part 13651044 · Oct 12, 2012
Related Publication 20140294741A1 · Oct 2, 2014